A Study on Triptolide Protects Against Lipopolysaccharide- Induced Endotoxemia by Anti Inflammation Effect

Zheng Wu,Cheng Lu,Yunjian Liao,Jiahong Chen,Jun Liu,Youwei Huang,Xi Lin
DOI: https://doi.org/10.3923/ijp.2016.597.604
2016-01-01
International Journal of Pharmacology
Abstract:Background and Objective: Triptolide (TPL) is an extracts of the root of Chinese herb Tripteryginin, which have anti-carcinogenesis effects, immunosuppressive and anti-inflammatory response. The present study was designed to evaluate the anti -inflammation effect of triptolide. Methodology: The endotoxemia models were established by intraperitoneally (i.p.) injecting 30 mg kg(-1) purified LPS in BALB/c mice. The treatment groups were injected intraperitoneally different doses (1.0, 2.0 and 5.0 mg kg(-1)) of TPL 30 min before LPS infusion. Survival rate was monitored for 7 days and serum TNF-alpha, ALT and BUN levels were determined. In vitro, endotoxemia cell models were established by given 1 mu g mL(-1) in RAW 264.7 murine macrophage cell. The concentration of TNF-alpha and IL-1 beta was detected and the protein levels of TNF-alpha and IL-1 beta were determined. Results: A rise TNF-alpha and IL-1 beta level in serum and the increase of BUN and ALT level. While TPL treatment significantly increased survival rate in LPS-induced endotoxemia mice model, decreased the levels of ALT, BUN and serum TNF-alpha and IL-1 beta. In vitro, LPS-induced TNF-alpha and IL-1 beta production was inhibited by TPL. Conclusion:These findings suggested that TPL had the ability of antiendotoxemia and protecting LPS-induced organ injuries by decreasing TNF-a and IL-1 beta level.
What problem does this paper attempt to address?